Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study.
The purpose is to determine the safety, tolerability, systemic exposure and pharmacokinetics
of ME1111 after repeated daily topical application of ME1111 in a maximal use setting in
adults with distal subungual onychomycosis of the toenails.